series-b
Stage
2
Investors
About
NovoGI is developing a novel, non-invasive diagnostic platform for gastrointestinal diseases. Their technology uses advanced biomarker analysis for early detection of conditions like inflammatory bowel disease (IBD) and colorectal cancer.
Explore NovoGI's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.